在脏生理学和病理生理学中的乙化
Jian-Yu Zhang1, Jun Wu2, Zi-Han Chen1
1School of Life Science, Northwest University, Xi'an, Shaanxi, China.
Frontiers in pharmacology
|October 17, 2025
概括
基因组脱乙酶 (HDACs) 和素酶 (SIRTs) 调节蛋白质乙化,影响脏疾病. 本综述探讨了它们在保护和损伤方面的作用和治疗潜力.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 生物化学 生化学
- 分子生物学分子生物学
背景情况:
- 像AKI和CKD这样的脏疾病是全球重要的健康问题.
- 由HDACs和SIRTs调节的蛋白质乙化,影响脏病理生理学.
- 了解这些酶对于开发新的病治疗方法至关重要.
研究的目的:
- 审查HDAC和SIRT在病中的作用和机制.
- 探索HDAC抑制剂和SIRT激活剂在脏保护中的治疗潜力.
- 讨论SIRT在损伤和保护中的双重作用.
主要方法:
- 关于HDACs,SIRTs和病的研究的文献综述.
- 对乙化对病理生理学影响的机制的分析.
- 检查涉及HDAC抑制剂和SIRT调节器的治疗策略.
主要成果:
- HDACs和SIRTs通过蛋白质乙化显著影响病的进展.
- 一些SIRT具有双重作用,根据上下文提供保护或造成伤害.
- 在临床前和临床环境中,HDAC 抑制剂和 SIRT 激活剂对脏保护具有前景.
结论:
- HDACs和SIRTs是脏疾病的关键调节剂,提供治疗点.
- 针对SIRT,特别是具有双重作用的SIRT,需要仔细考虑,以有效管理病.
- 对HDAC和SIRT调制的进一步研究为新性病治疗提供了显著的潜力.
相关概念视频
Phase II Reactions: Acetylation Reactions
752
Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
752
Acute Kidney Injury II: Pathophysiology
876
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
876
Renal Regulation of Acid-Base Balance
1.5K
Metabolic reactions in the body produce nonvolatile acids, such as sulfuric acid, which generate an acid load of approximately 1 mEq of H+ per kilogram of body weight daily. Excreting H+ in the urine is essential to balance this acid load.
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
1.5K
Acute Kidney Injury IV: Diagnostic Studies and Prevention
257
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
257
Acute Kidney Injury V: Interprofessional Care
295
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
295
Renal Drug Excretion: Tubular Reabsorption
728
Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
728


